Podcasts about Respiratory disease

Is that cough the flu or COVID? Lester Kiewit speaks to Dr Sibongile Walaza, epidemiologist at the Centre for Respiratory Diseases and Meningitis, to learn the difference. Good Morning Cape Town with Lester Kiewit is a podcast of the CapeTalk breakfast show. This programme is your authentic Cape Town wake-up call. Good Morning Cape Town with Lester Kiewit is informative, enlightening and accessible. The team’s ability to spot & share relevant and unusual stories make the programme inclusive and thought-provoking. Don’t miss the popular World View feature at 7:45am daily. Listen out for #LesterInYourLounge which is an outside broadcast – from the home of a listener in a different part of Cape Town - on the first Wednesday of every month. This show introduces you to interesting Capetonians as well as their favourite communities, habits, local personalities and neighbourhood news. Thank you for listening to a podcast from Good Morning Cape Town with Lester Kiewit. Listen live on Primedia+ weekdays between 06:00 and 09:00 (SA Time) to Good Morning CapeTalk with Lester Kiewit broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/xGkqLbT or find all the catch-up podcasts here https://buff.ly/f9Eeb7i Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Barry Quart, CEO of Connect Biopharma, is developing the next generation of monoclonal antibodies targeting inflammatory respiratory diseases such as COPD and asthma. Administered subcutaneously, their lead program targets IL-4 and has demonstrated the ability to rapidly improve airway function and reduce the incidence of acute exacerbations in these patients. Current treatments rely on steroids and bronchodilators, which do not address the underlying inflammatory causes, an area that has largely been under-addressed by other biologic developers. Barry explains, "Connect has been dedicated for quite a few years to designing next-generation monoclonal antibodies targeting inflammatory diseases. I joined the company last year and really kind of turned the ship towards a sole focus on our lead program, which is rademikibart, a second-generation Dupixent, a monoclonal antibody targeting IL-4, a really important target for certain inflammatory diseases." "IL-4 can be used as a monoclonal antibody targeting IL-4 for diseases such as atopic dermatitis, asthma, and COPD, as well as several other conditions. We're focused on asthma and COPD. So, inflammatory respiratory disease, because our product has some unique characteristics that are going to allow us to focus on an area that's really been completely ignored by other developers of biologics in the respiratory space, and specifically on patients having acute exacerbations."  #ConnectBiopharma #MonoclonalAntibody #IL4 #COPD #Asthma #AtopicDermatitis #InflammatoryDiseases #RespiratoryDiseases connectbiopharm.com Download the transcript here

Barry Quart, CEO of Connect Biopharma, is developing the next generation of monoclonal antibodies targeting inflammatory respiratory diseases such as COPD and asthma. Administered subcutaneously, their lead program targets IL-4 and has demonstrated the ability to rapidly improve airway function and reduce the incidence of acute exacerbations in these patients. Current treatments rely on steroids and bronchodilators, which do not address the underlying inflammatory causes, an area that has largely been under-addressed by other biologic developers. Barry explains, "Connect has been dedicated for quite a few years to designing next-generation monoclonal antibodies targeting inflammatory diseases. I joined the company last year and really kind of turned the ship towards a sole focus on our lead program, which is rademikibart, a second-generation Dupixent, a monoclonal antibody targeting IL-4, a really important target for certain inflammatory diseases." "IL-4 can be used as a monoclonal antibody targeting IL-4 for diseases such as atopic dermatitis, asthma, and COPD, as well as several other conditions. We're focused on asthma and COPD. So, inflammatory respiratory disease, because our product has some unique characteristics that are going to allow us to focus on an area that's really been completely ignored by other developers of biologics in the respiratory space, and specifically on patients having acute exacerbations."  #ConnectBiopharma #MonoclonalAntibody #IL4 #COPD #Asthma #AtopicDermatitis #InflammatoryDiseases #RespiratoryDiseases connectbiopharm.com Listen to the podcast here

AABP Executive Director Dr. Fred Gingrich reviews a paper published in The Bovine Practitioner with the first author Madeline Mancke from Kansas State University. The objective of this study was to determine potential associations between Cardiac Troponin I (cTnI) serum concentration of cattle at initial bovine respiratory disease (BRD) treatment with the risk of retreatment or mortality at 60 days. BRD is the most significant disease in beef cattle and is a major cause of morbidity and mortality. Developing prognostic tools may be valuable for managing individual cases. cTnI is a protein that is released into the circulatory system after myocardial damage and may be useful as a biomarker for prognostication of BRD cases. Mancke walks through the results of the paper which demonstrated that 8/318 samples had high cTnI levels and animals with high cTn1 concentrations had a significantly greater probability of not finishing the 60-day post-enrollment period. Cattle with high cardiac troponin concentrations at initial BRD treatment were more likely to have negative clinical outcomes but, in this study, very few animals had high cTnI levels. Mancke provides information about potential future research opportunities to better manage BRD cases in the feedyard.  The Bovine Practitioner is the peer-reviewed journal published by AABP. The journal publishes original research, case studies, review articles and case studies that are intended to provide information to the practicing cattle veterinarian. The journal is available open-access online and print volumes are available for purchase. There are no publication fees for authors and the peer review and submission process is managed online. Find the journal at this link.  Evaluation of cardiac troponin I as a predictor of clinical outcomes in cattle treated for bovine respiratory disease (BRD) in commercial feedyards. Bov Pract. 2025;59(1), 24-28. https://doi.org/10.21423/bpj20259053 

When you're in an environment where the air is dry, a whole cascade of responses renders you more susceptible to respiratory conditions and diseases. That's according to research by respiratory health expert David Edwards at Johns Hopkins. Edwards: It's understood … How are dry air and respiratory disease connected? Elizabeth Tracey reports Read More »

Dr. Zach Bush, a renowned physician and regenerative farming advocate, discusses the importance of soil health on human and pet health. He explains that 97% of global soils are depleted, leading to nutrient-poor crops and chronic diseases. He emphasizes regenerative farming practices that focus on biodiversity and soil health, which can restore soil fertility and improve crop yields. Dr. Zach also introduces his product, ION, derived from ancient fossil soils, which enhances cellular communication and mitochondrial metabolism, promoting health and longevity in both humans and pets. Dr. Judy Morgan shares her personal experience with soil and farming challenges, highlighting the need for better soil management and nutrition for pets. So much great, great information! ZBMD http://zachbushmd.com/ ION* https://intelligenceofnature.com/ FARMER'S FOOTPRINT: http://www.farmersfootprint.us/ THE JOURNEY OF INTRINSIC HEALTH: https://journeyofintrinsichealth.com/ PRODUCT SPOTLIGHT #1 As their trusted guardians we are responsible for Keeping our pets safe from harm. In today's world that's getting harder than ever. Unfortunately, our pets are constantly exposed to damaging and virtually unavoidable toxins like glyphosate. This exposure weakens their immune systems, causes inflammation and disrupts the microbiome. One of the best things you can do to help protect your pet is to ensure their natural defenses are at their strongest. That's where ION Gut Support for Pets can help. ION Gut Support for Pets is proven to strengthen the gut lining within minutes, supporting your pet's innate ability to defend against toxins, while promoting healthy digestion, immune function and kidney health. We can't remove the world's harmful toxins, but we can help make living in it safer for our loved ones, especially the furry ones who entrust us with their care. Try ION Gut Support for Pets today. Order now at intelligenceofnature.com and save 15% off your first order of ION with the code DRJUDY. Please note that Naturally Healthy Pets may receive a commission on any orders placed with our code. PRODUCT SPOTLIGHT #2 Respiratory Diseases in dogs can cause significant distress. They include laryngeal paralysis, collapsing trachea, pulmonary fibrosis, chronic bronchitis, infectious disease, cancer, tumors, heart disease. Luckily, integrative veterinarian Dr Judy Morgan has created a comprehensive short course that addresses common respiratory diseases and how to use traditional Chinese Veterinary Medicine, food therapy, supplements and hands on care to ensure your pet retains a vibrant life. Podcast listeners can take advantage of 20% off of Respiratory Diseases in Dogs by using the code PODCAST54 when ordering on DrJudyU.com.

The National Cancer Institute is exploring a new new tech-based treatment to help patients overcome a severe breathing disorder caused by the Human Papilloma Virus. Leaders from the agency's Center for Cancer Research — Dr. Clint Allen, a senior investigator, and Dr. Scott Norberg, an associate research physician — join us to discuss the findings from their recent study on the Recurrent Respiratory Papillomatosis, which can cause damage to the vocal cords and block airways, making it hard to breathe. Allen and Norberg shared details about the therapy, which uses a gorilla adenovirus based-technology to target the infection.

In this podcast Phil Elkins discusses respiratory diseases in cattle, essentially preventive versus reactive care, and ensuring farm vets and farmers engage on countering the threats. Phil Elkins qualified in 2005 from The University of Edinburgh and, following stints in Cheshire and New Zealand, spent the majority of his career in clinical practice in Cornwall, during which time he gained a certificate in advanced veterinary practice in cattle. Following 15 years in clinical practice and a stint working for an agri-tech company, Phil now works as an independent consultant to both farms and industry bodies. He is a former council member of the BVA. He wrote “Respiratory disease in cattle: preventive versus reactive care” for Vet Times Livestock (2025), Volume 11, Issue 1, Pages 9-10 (which went out with Vet Times Volume 55, Issue 12). The article is available online at vettimes.com [https://www.vettimes.com/clinical/livestock/respiratory-disease-in-cattle-preventive-versus-reactive-care] SPONSORED This podcast is sponsored by Zoetis, which has recently launched Protivity, the UK's first authorised Mycoplasma bovis vaccine for cattle. What if you could be proactive instead of reactive when it comes to Mycoplasma bovis? Protivity, the first modified-live vaccine for Mycoplasma bovis in cattle, is now available in the UK. The days of relying on antibiotics alone to help control Mycoplasma bovis are over. It's time to change the game for your herds with Protivity. To learn more, UK veterinary professionals can visit the website. [https://bit.ly/4jRJxv3]

A vet shares the latest on transmission, prevention, and what pet owners should look out for to keep their dogs healthy and safe

A vet shares the latest on transmission, prevention, and what pet owners should look out for to keep their dogs healthy and safe

In this episode of the Medical Nursing Podcast we're talking about a really common, commonly misunderstood and often frustrating disease - feline respiratory disease complex, aka FRDC or cat ‘flu. When I think about those ‘flu cases, I think back to sweating in PPE in a makeshift isolation room in my earlier nursing days, spending countless hours cleaning nasal discharge, creating steam baths outside of kennel doors, and tempting tiny kittens to eat. This is a disease that is MADE for nursing - there is so much we can do to support these patients. And as always, giving that great care starts with understanding what ‘flu is, and how we manage it - which is exactly what's waiting for you inside this episode. --- Resources mentioned in this episode:

Dr. Luke Strehle of Nebraska Vet Services, a full-service mixed animal practice based in West Point, Nebraska, joins us to share his insight on swine respiratory pathogens – how to reduce and eliminate their risk as well what interventions are available to manage pig health. This episode is brought to you by Pharmgate Animal Health, a growing business that puts livestock first. Pharmgate provides a proven portfolio of technically supported, high-quality products that are the foundation of custom herd health protocols. By offering multiple options for active ingredients, concentrations, and administration routes, Pharmgate provides you with choices to fit your needs backed by a team with technical expertise to get the results you want.

Vaccinations play an important role in both our individual and community health. They help to prevent serious and sometimes deadly diseases by strengthening our immune system. But in recent years this cost effective method of disease prevention has come under the spot light, drawing attention to some myths and misconceptions. In this episode, Dr Anne von Gottberg dives into the importance of vaccinations, how to handle missed vaccines, vaccine dos and don'ts and recent changes in the Extended Programme onIimmunzation(EPI) in South Africa.About our Guest: Dr Anne von Gottberg is currently the laboratory lead at the Centre for Respiratory Diseases and Meningitis at the National Institute for Communicable Diseases, Johannesburg, South Africa; and Associate Professor within the School of Pathology, Faculty of the Health Sciences, University of the Witwatersrand, Johannesburg; and Honorary Professor, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town. She leads a laboratory team responsible for reference diagnostics for respiratory and meningitis pathogens nationally and regionally. The laboratory is the regional reference laboratory for the World Health Organization (WHO) Vaccine-preventable Invasive Bacterial Diseases (VP-IBD) Coordinated Global Surveillance Network for the southern African region; a National Influenza Centre (NIC); and a global WHO RSV and regional SARS-CoV-2 reference laboratory. She is currently a member of several committees and technical advisory groups for AFRO, Africa CDC and WHO. Her main interests include surveillance for meningitis and respiratory pathogens, assessing vaccine effectiveness where relevant. She has authored or co-authored more than 200 articles in peer-reviewed journals. In addition, she supervises a number of Masters and PhD students. Dr von Gottberg obtained her MBBCh and PhD at the University of the Witwatersrand, and trained for her specialisation in clinical microbiology (FC Path[SA] MICRO) at the National Health Laboratory Service (former South African Institute for Medical Research) and at the University of the Witwatersrand.WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: mail.microbe@gmail.com

Join Tanya Laidlaw, MD, FAAAAI, for a detailed and insightful conversation about the pathophysiology of AERD as well as the diagnosis and current management strategies.  

Joining us for this episode of Feedstuffs in Focus is Dr. David Baumert, Senior Technical Services Veterinarian at Zoetis Pork, to discuss the reasons why producers sometimes choose not to treat pigs — usually heavier weight finishers — in need of swine respiratory disease (SRD) therapy and the implications of non-use from a performance, labor and economic standpoint. This episode of Feedstuffs in Focus has been brought to you by Zoetis Pork.IMPORTANT SAFETY INFORMATION: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCENEL RTU EZ. Do not use in swine found to be hypersensitive. Withdraw 6 days prior to slaughter when injection site volumes are greater than 5 mL up to 15 mL per injection site and 4 days prior to slaughter when injection site volumes are less than or equal to 5 mL per injection site. See full Prescribing Information at Excenelpork.com/PI.ReferencesPantoja L, Kuhn M, Farrand E, et al. Impact of a Husbandry Education Program on nursery pig mortality, productivity, and treatment cost. Journal of Swine Health and Production [serial online]. 2013;21 (4):188-194. Available from: CAB Abstracts, Ipswich, MA. Accessed May 1, 2018. Pineiro C, Morales J, Doncecchi P, et al. Individual Pig Care program improves productive performance and animal health in nursery-growing pigs. Journal of Swine Health and Production [serial online]. 2014;22 (6):296-299. Available from: CAB Abstracts, Ipswich, MA. Accessed August 1, 2018.Bowersock, T. L., Meeuwse, D. M., Kausche, F. M., Lucas, M. J., Bryson, W. L. and Dame, K.J. Efficacy of ceftiofur crystalline free acid and ceftiofur hydrochloride administered intramuscularly in swine inoculated with Actinobacillus pleuropneumoniae. Pharmacia Animal Health. 2001. Data on file, Study Document No. ZRD-PSC-004402, Zoetis Inc.All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. © 2024 Zoetis Services LLC. All rights reserved. EXC-00084

Guidelines from the American Thoracic Society report on the value of pulmonary rehabilitation for people with COPD, interstitial lung disease, or pulmonary hypertension. JAMA Clinical Guidelines Synopsis author Michaela R. Anderson, University of Pennsylvania, discusses these guidelines and more with JAMA Associate Editor David Simel, MD, MHS. Related Content: Pulmonary Rehabilitation for Adults With Chronic Respiratory Disease Proper Use of Inhalant Medications for Chronic Respiratory Diseases

Infectious upper respiratory disease, or I-U-R-D, is a scourge to kittens — especially those…

Infectious upper respiratory disease, or I-U-R-D, is a scourge to kittens — especially those in multi-cat situations. Beyond targeting the respiratory tract, the pathogens — like herpesvirus — can cause...

NEWS: DOH warns of more respiratory diseases | Jan. 9, 2025Visit our website at https://www.manilatimes.netFollow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotionSubscribe to our Digital Edition - https://tmt.ph/digitalSign up to our newsletters: https://tmt.ph/newslettersCheck out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes Hosted on Acast. See acast.com/privacy for more information.

Ray White in conversation with Prof. Cheryl Cohen, Head of the Centre for Respiratory Diseases and Meningitis at the National Institute of Communicable Diseases about the implications for South Africa and whether we should be concerned in the aftermath of the respiratory virus outbreaks in China. See omnystudio.com/listener for privacy information.

IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP, discusses the 2024-2025 respiratory illness season with Brendan Jackson, MD, MPH, Director of the Office of Readiness, Response and Operations at the CDC National Center for Immunization and Respiratory Diseases.

Jeffrey Ekoma, ASTHO Senior Director for Government Affairs, tells us what to expect from Congress as the year wraps up; Dr. Brendan Jackson, Director of the Office of Readiness, Response, and Operations for the CDC's National Center for Immunization and Respiratory Diseases, discusses the current state of respiratory virus season as we wrap up National Influenza Vaccination Week; and ASTHO has compiled a number of evidence-based technical packages for your use. ASTHO Web Page: Stay Informed CDC Web Page: About National Influenza Vaccination Week ASTHO Web Page: Evidence-Based Public Health  

Dando sequência à série "Naruhodo Entrevista" de conversas descontraídas com cientistas brasileiras e brasileiros, chegou a vez da Médica, Doutora em Fisiopatologia em Clínica Médica e Livre Docência em Pneumologia, Suzana Tanni.Só vem!> OUÇA (90min 14s)*Naruhodo! é o podcast pra quem tem fome de aprender. Ciência, senso comum, curiosidades, desafios e muito mais. Com o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza.Edição: Reginaldo Cursino.http://naruhodo.b9.com.br*Suzana Erico Tanni possui graduação em Medicina pela Universidade Estadual Paulista Júlio de Mesquita Filho (1998), doutorado em Fisiopatologia em Clínica Médica [Botucatu] pela Universidade Estadual Paulista Júlio de Mesquita Filho (2008) e Livre Docente em Pneumologia pela Universidade Estadual Paulista Júlio de Mesquita Filho (2018). Atualmente é Professora Associada da Universidade Estadual Paulista Júlio de Mesquita Filho. Foi presidente da Sociedade Paulista de Pneumologia e Tisiologia (2022-2023). Coordenadora da Comissão de Epidemiologia e Pesquisa Clínica da Sociedade Brasileira de Pneumologia e Tisiologia, com responsabilidade na construção de guidelines nacionais de conteúdo respiratório.Desde 2010 atua como Docente do curso MECOR - Methods in Epidemiologic, Clinical and Operations Research da American Thoracic Society e da Associación Latino Americana do Thorax. Atualmente é Docente Líder do nível 2, para realização de manual de procedimento operacionais e plano de análise estatística.É Editora Associada do periódico Jornal Brasileiro de Pneumologia na área de Epidemiologia e DPOC, na Revista Médica Brasileira na área de pneumologia e da Frontiers Medicine-Respiratory Diseases. Atua como "Guest Editor" nos periódicos Frontiers in Case Report in Respiratory Diseases e Women in Science: Pulmonary Medicine 2023.Desde 2008, atua em Estudos Multicêntricos sobre Doenças Respiratórias. Faz parte do 4-Consortium for Clinical Characterization of COVID-19 By EHR (4CE) liderado por pesquisadores da Harvard Medical School, Boston, USATem experiência na área de Medicina, com ênfase em Pneumologia, atuando principalmente no seguinte tema: doenças pulmonares; doença pulmonar obstrutiva crônica, tabagismo e covid-19.Lattes: http://lattes.cnpq.br/4887507894734442*APOIE O NARUHODO PELA PLATAFORMA ORELO!Um aviso importantíssimo: o podcast Naruhodo agora está no Orelo: https://bit.ly/naruhodo-no-oreloE é por meio dessa plataforma de apoio aos criadores de conteúdo que você ajuda o Naruhodo a se manter no ar.Você escolhe um valor de contribuição mensal e tem acesso a conteúdos exclusivos, conteúdos antecipados e vantagens especiais.Além disso, você pode ter acesso ao nosso grupo fechado no Telegram, e conversar comigo, com o Altay e com outros apoiadores.E não é só isso: toda vez que você ouvir ou fizer download de um episódio pelo Orelo, vai também estar pingando uns trocadinhos para o nosso projeto.Então, baixe agora mesmo o app Orelo no endereço Orelo.CC ou na sua loja de aplicativos e ajude a fortalecer o conhecimento científico.https://bit.ly/naruhodo-no-orelo

There is a new convenient, one-shot, low-volume antibiotic from Elanco Animal Health that offers swine respiratory disease treatment protocol flexibility from nursery to finish. Pradalex has a unique structure that differs from any molecule in its class. What opportunities might Pradalex have for your hog operation. Joining us to share his experience and trial work to date with Pradalex is veterinarian Dr. Paul Thomas of AMVC.This episode of Feedstuffs in Focus is brought to you by Elanco Animal Health. Learn more about Elanco at farmanimal.elanco.com/us/swine 

This episode explores how COVID-19 is a systemic disorder affecting multiple organs and the potential therapeutic role of neutralizing micro RNA 2392. It also discusses new findings on the association between serotonin reduction and the neurological and cognitive symptoms in long COVID patients. Looking for the YouTube version? Click here to watch now! Get Functional Diagnostic Nutrition's best workshops and freebies at fdntraining.com/resources.

Respiratory diseases like the flu or RSV are common during the Fall and Winter, but how do you know when your symptoms mean you should seek medical care? And what steps can you take to protect yourself from getting sick in the first place? What is different this fall and winter? And how and when do vaccines get approved anyway? Host Dr. Anne Zink and guests discuss managing respiratory diseases and staying healthy this fall and winter.

Swine respiratory disease (SRD) is a commonly encountered health challenge in today's hog industry. SRD includes a wide range of bacterial pathogens that can impact pig respiratory systems as well as the overall health of a farm system. What might all this mean for your operation, and how can you fight back? This episode is brought to you by Pharmgate Animal Health, a growing business that puts livestock first. Pharmgate provides a proven portfolio of technically supported, high-quality products that are the foundation of custom herd health protocols. By offering multiple options for active ingredients, concentrations, and administration routes, Pharmgate provides you with choices to fit your needs backed by a team with technical expertise to get the results you want.Joining us today on Feedstuffs in Focus is Dr. Nic Lauterbach, technical services veterinarian with Pharmgate Animal Health. Our topic is that of how swine respiratory disease can be stopped in its tracks through the implementation of practical strategies and recommendations for improving herd health outcomes when faced with the threat of swine respiratory disease.To access more SRD resources and connect with an expert, visit Pharmgate.com.

About this episode: Respiratory syncytial virus can be particularly dangerous for older adults and infants and this year, for the first time, there are three approved and readily available products to help prevent severe disease: A vaccine for pregnant women and people over age 65, and an antibody treatment for infants born during RSV season. In this episode: all about these products and they promise they show for dramatically reducing the number of hospitalizations and deaths from RSV this year. Guests: Dr. Georgina Peacock is the director of the Immunization Services Division in the National Center on Immunization and Respiratory Diseases at the CDC. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Surveillance of RSV—CDC Why So Many Babies Didn't Get RSV Vaccines This Winter—Public Health On Call (February, 2024) Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on X @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

Recently, a study was conducted at the university of Auckland analysing the use of A.I in predicting the prevalence of respiratory disease outbreaks during flu seasons in Aotearoa. Forecasting models are essential for hospitals in predicting admissions and subsequently allocating resources and beds. However, during peak flu periods, and, most notably the height of the COVID-19 pandemic, hospitals across Aotearoa have been largely underprepared for respiratory disease outbreaks, hence why experts have called for improvements to be made to traditional forecasting models.  Oto spoke to Dr Steffen Albrecht, a Research Fellow at the School of Computer Science at the University of Auckland and author of the study, to talk about the study and how A.I could help disease forecasting models in hospitals across Aotearoa. 

Dr. Brad White of Kansas State University and Director of the Beef Cattle Insitute talks about his team's research into Bovine respiratory disease, or Shipping Fever. Bovine respiratory disease costs ranchers in the United States about $900 million annually due to animal death, reduced feed efficiency and treatment costs. The research represents the most comprehensive assessment of risk factors and pathological characteristics of late day pulmonary disease ever reported, generating valuable results that will help ranchers and veterinarians improve animal welfare, mitigate the negative impacts of this disease while promoting antimicrobial stewardship.

Professor Anne von Gottberg. Co-head of the Centre for Respiratory Diseases and Meningitis NICD weighs in on a US study which further corroborates the origins of COVID-19 – from animals at a market stall in Wuhan, China.See omnystudio.com/listener for privacy information.

What sickness is going around right now? Is bird flu worse in fall? What is sloth fever? How is cholera transmitted? When is respiratory virus season 2024? AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, covers the latest outbreak news today and discusses new viruses going around 2024. American Medical Association CXO Todd Unger hosts.

The number of New Zealanders suffering from respiratory diseases is worse than previously thought. A new report by the the Asthma and Respiratory Foundation found 1 in 5 New Zealanders are affected, up from 1 in 7 people in 2021. Letitia Harding spoke to Corin Dann.

Respiratory diseases costs the country more than $8 billion each year. New research has found more Kiwis are suffering than previously thought, with around one million people affected by the disease annually. Asthma and Respiratory Foundation Chief Executive Letitia Harding says the financial burden is huge. "We base all of this on our prescriptions, our hospitalisations, time off work, school days lost - because then you have parents who take time off as well - a lot of factors go into this." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Dr. Tess Eidem a practitioner and researcher working with the cannabis industry. She is interested in IEQ issues from a very broad perspective such as relative humidity and ventilation to very specific topics such as Bioaerosol exposures when cultivating cannabis. This week we will explore cannabis production, the worker health issues it poses and how we can learn from this new and quickly expanding area. Her most recent paper with Tara Nordgren and Mark Hernandez is on Bioaerosol Exposures and Respiratory Diseases in Cannabis Workers.  Tess Eidem's doctoral research focused on developing novel antibiotics against bacterial pathogens, and her scientific career has centered on bringing modern microbiology and RNA biology practices to promote human health. Leveraging her scientific expertise, Dr. Eidem transitioned into the cannabis industry where she spent four years working directly in cannabis production and quality management. This unique experience allowed her to combine her hands-on skills in manufacturing with microbiology and product safety as a Preventive Controls Qualified Individual (PCQI) to help cannabis cultivators minimize potential hazards within their facilities and in their products. Having witnessed firsthand the challenges of microbial contamination in the cannabis industry, Dr. Eidem returned to the University of Colorado Boulder, where she currently works as a Senior Research Scientist in the Aerobiology and Disinfection Laboratory, with a focus on practical building science. Her research investigates bioaerosol persistence associated with cannabis environments, including airborne molds, allergens, and pathogens. She is driven to connect unbiased scientific research with environmental engineering principles and applying them to the cannabis space to improve worker well-being, plant health, and consumer safety.

AABP Executive Director Dr. Fred Gingrich is joined by Dr. Brad White from the Kansas State University Beef Cattle Institute to discuss a paper published in the Bovine Practitioner titled “Risk factors Associated with Case Fatality and Treatment Success following Initial Bovine Respiratory Disease Treatment in Feedyard Cattle”. This paper was a retrospective analysis of existing feedyard data to identify potential relationships between risk factors known at the time of initial treatment for bovine respiratory disease (BRD) and treatment outcomes. The three post-treatment outcomes evaluated were first treatment success, post-treatment deaths from any cause, and post-treatment deaths due to BRD.  The investigators found the overall first treatment success for BRD to be 67.8% with all-cause mortality of 10% and BRD related mortality of 6.3%. White discusses associations found with each post-treatment outcome evaluated which can be useful information as veterinarians evaluate the success of their BRD treatment, prevention and control protocols for their customers, and define expectations with clients.  Neal, K. B., White, B. J., Amrine, D. E., Lubbers, B. V., Tessman, R. K., & Larson, R. L. (2024). Risk factors Associated with Case Fatality and Treatment Success following Initial Bovine Respiratory Disease Treatment in Feedyard Cattle. The Bovine Practitioner, 58(2), 1–8. https://doi.org/10.21423/bovine-vol58no2p1-8 

In this episode of the SMFM Podcast Series, Dr. Marwan Ma'ayeh hosts a timely discussion on preparing for the annual respiratory disease season. Our guests, Dr. Brenna Hughes and Dr. Naima Joseph share valuable insights into the latest CDC guidelines and recommendations for managing respiratory illnesses, including COVID-19, flu, and RSV, during the 2024-2025 season. They discuss the importance of vaccinations, including the RSV vaccine available for pregnant patients, and how healthcare providers can support their patients and staff through the upcoming season. Tune in for essential updates and practical advice to help navigate this respiratory disease season effectively. Additional Links: SMFM COVID-19 Clinical Guidance SMFM RSV Clinical Guidance  Patient Education Website Click here to access the full transcript.

In this VETgirl podcast, we interview Dr. Carol Reinero on what's new with CIRDC in dogs. What pathogens cause CIRDC, and how do we protect our canine patients? Tune in as she discusses how to get your “social dogs” protected, how we treat CIRDC, and what kind of tests should be run in isolated cases of suspected CIRD and in suspected outbreaks of CIRD!

Bovine Respiratory Disease (BRD) causes an estimated $800 to $900 million annually in economic losses from death, reduced feed efficiency, and treatment costs. Newly weaned calves are especially susceptible to BRD and other respiratory concerns. As a cattle producer, what are your options and solutions?  Joining us on this episode of Feedstuffs in Focus to talk about trace minerals and immunity in weaned calves is Roberto Palomares, DVM, and Kevin Cain, DVM.This podcast is brought to you by Axiota Animal Health. Axiota discovers, develops, and commercializes scientifically proven products, such as Multimin® 90 and Lactipro®.  Axiota's non-antibiotic solutions support beef and dairy producers' goals of optimal health, performance, and animal well-being. To learn more, visit www.axiota.com.IMPORTANT SAFETY INFORMATION FOR MULTIMIN ® 90: Not for use in humans, keep out of reach of children. Multimin 90 has a preslaughter withdrawal time of 14 days after injection. Do not use during the first trimester of pregnancy or in pre-ruminant calves as safety has not been established. Selenium and copper are toxic if administered in excess and may lead to sudden death, depression, weakness, ataxia, salivation, and drooling. Do not use concurrently with other selenium or copper injections or boluses. Maximum volume per injection site is 7 mL. Allow a minimum of 30 days before considering repeat dosing. See prescribing information at axiota.com/label 

Dr Sibongile Walaza, head of epidemiology at the Centre for Respiratory Diseases and Meningitis at the NICD shares a Covid update and whether further vaccinating is necessary. See omnystudio.com/listener for privacy information.

This week we continue our partnership with the College of Veterinary Medicine as I have a discussion with Dr. Jared Taylor about bovine respiratory disease . This disease complex is one very common to every beef producer in the industry. We vaccinate for this disease and have excellent treatment methods but Dr. Taylor and I [ Read More ]

Pandemics are on the rise. Will bird flu be next? The government says it's monitoring the situation, but should we worry? According to former National Security Council Director for Medical and Biodefense Preparedness and expert on emerging infectious diseases, Luciana Borio, the answer is yes. Not only because bird flu is dangerous, but because the government may be giving us happy talk. The more you know, the better. So join us.

Mati Hlatshwayo Davis discusses the latest information on avian influenza with Demetre Daskalakis, MD, MPH, director of CDC's National Center for Immunization and Respiratory Diseases, Andrew Bowman, DVM, PhD, a veterinarian, epidemiologist and influenza expert at Ohio State University, and Katelyn Jetelina, MPH, PhD, an epidemiologist and data scientist.  *This episode was recorded on May 21, 2024.

Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Demetre Daskalakis is the Director of the CDC's National Center for Immunization and Respiratory Diseases. Hilary Marston is the Chief Medical Officer of the Food and Drug Administration. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin and Others. Audio Interview: Preparing for a Possible Avian Influenza Outbreak. N Engl J Med. DOI: 10.1056/NEJMe2406224.

You may have heard the saying, "An ounce of prevention is worth a pound of cure." Whether through genetics, management or vaccination, preventing Bovine Respiratory Disease (BRD) concerns in your herd should be at the top of most producer's to-do lists.On today's episode, you'll hear more from Shauna Hermel at CattleCon 2024 where she sat down with our guests, veterinarians D.L. Step of Boeringer Ingelheim and Dave Sjeklocha with Merck, to discuss their top tips for managing your herd and feeder calves to prevent disease issues.  Find more information to make Angus work for you in the Angus Beef Bulletin and ABB EXTRA. Make sure you're subscribed! Sign up here to the print Angus Beef Bulletin and the digital Angus Beef Bulletin EXTRA. Have questions or comments? We'd love to hear from you! Contact our team at abbeditorial@angus.org.

Dr. Brooke Cunningham, ASTHO Member and Health Commissioner for the Minnesota Department of Health, reflects on the importance of using policy to achieve racial equity; Dr. Priti Patel, Acting Director of the Office of Science in the National Center for Immunization and Respiratory Diseases at CDC, discusses a new study in the American Journal of Preventive Medicine that considers the public health role in the response to long COVID; and an ASTHO report examines the benefits of verbal screening when treating people using two or more substances during pregnancy. American Journal of Preventive Medicine Webpage: The Role of U.S. Public Health Agencies in Addressing Long COVID ASTHO Report: Polysubstance Use During Pregnancy and the Benefits of Universal Verbal Screening ASTHO Webpage: Stay Informed

A mysterious respiratory disease is affecting dogs across the country, in some cases causing serious illness and even death. Veterinarian Dr. Meghan Davis returns to the podcast to talk with Stephanie Desmon about what we know and don't know about these cases so far, and how data collection and surveillance will be key to learning more. They also discuss One Health, a public health approach bridging human, animal, and environmental health for surveillance against novel threats.